Literature DB >> 9465852

[Marfan syndrome: strategies of interdisciplinary care].

Y von Kodolitsch1, M Raghunath, C A Nienaber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9465852     DOI： 10.1055/s-2007-1023893

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  3 in total

1.  [Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (116 b SGB V)].

Authors:  Marie-Luise Manow; Nesrin Paulsen; Meike Rybczynski; Thomas Mir; Alexander M J Bernhardt; Hendrik Treede; Gunda Ohm; Bettina Fuisting; Uwe Rehder; Florian Meier; Marina Vogler; Thomas Meinertz; Karin Overlack; Yskert von Kodolitsch
Journal:  Med Klin (Munich)       Date:  2010-09-08

2.  The economic impact of Marfan syndrome: a non-experimental, retrospective, population-based matched cohort study.

Authors:  Dmitrij Achelrod; Carl Rudolf Blankart; Roland Linder; Yskert von Kodolitsch; Tom Stargardt
Journal:  Orphanet J Rare Dis       Date:  2014-06-23       Impact factor: 4.123

Review 3.  The role of the multidisciplinary health care team in the management of patients with Marfan syndrome.

Authors:  Yskert von Kodolitsch; Meike Rybczynski; Marina Vogler; Thomas S Mir; Helke Schüler; Kerstin Kutsche; Georg Rosenberger; Christian Detter; Alexander M Bernhardt; Axel Larena-Avellaneda; Tilo Kölbel; E Sebastian Debus; Malte Schroeder; Stephan J Linke; Bettina Fuisting; Barbara Napp; Anna Lena Kammal; Klaus Püschel; Peter Bannas; Boris A Hoffmann; Nele Gessler; Eva Vahle-Hinz; Bärbel Kahl-Nieke; Götz Thomalla; Christina Weiler-Normann; Gunda Ohm; Stefan Neumann; Dieter Benninghoven; Stefan Blankenberg; Reed E Pyeritz
Journal:  J Multidiscip Healthc       Date:  2016-11-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.